Response to comments on: Butler et al. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes 2013;62:2595-2604

Diabetes. 2013 Oct;62(10):e19-22. doi: 10.2337/db13-0996.

Authors

Alexandra E Butler¹, Martha Campbell-Thompson, Tatyana Gurlo, David W Dawson, Mark Atkinson, Peter C Butler

Affiliation

¹ Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.

No abstract available

Publication types

Letter
Comment

MeSH terms

Diabetes Mellitus, Type 2 / drug therapy*
Female
Humans
Incretins / therapeutic use*
Insulin-Secreting Cells / drug effects*
Male
Pancreas / drug effects*

Substances

Incretins